Clinical Roundup Community cancer care linked with poorer outcomes for some head/neck cancers January 05, 2024Vol.50 No.01
Clinical Roundup Novel liquid biopsy of lymph fluid could guide precision treatment for head and neck cancer January 05, 2024Vol.50 No.01
Clinical Roundup Jemperli + Zejula improved PFS in advanced or recurrent endometrial cancer in RUBY Part 2 phase III trial January 05, 2024Vol.50 No.01
Clinical Roundup Inavolisib combination demonstrates 57% PFS in breast cancer indication January 05, 2024Vol.50 No.01
Clinical Roundup Kadcyla demonstrates OS benefit in breast cancer indication January 05, 2024Vol.50 No.01
Clinical Roundup Merck, Moderna initiate phase III INTerpath-002 study evaluating V940 (mRNA-4157) + Keytruda in NSCLC indication January 05, 2024Vol.50 No.01
Clinical Roundup CAR T-cell therapy for T-cell lymphoma shows promise in phase I study January 05, 2024Vol.50 No.01
Drugs & Targets FDA approves Padcev + Keytruda for locally advanced or metastatic urothelial cancer January 05, 2024Vol.50 No.01
Drugs & Targets European Commission authorizes Jemperli plus chemo in endometrial cancer indication January 05, 2024Vol.50 No.01
